Clinical Trials Browser

Prostatic Neoplasms × decitabine and cedazuridine drug combination × Clear all

NCT05037500 2025-11-12

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms